Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
Monthly Prescribing Reference
2h
FDA Drug Approval Decisions Expected in November 2024
The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug ...
Monthly Prescribing Reference
6h
Navenibart Gets Orphan Drug Status for Hereditary Angioedema
The Food and Drug Administration (FDA) has granted Orphan Drug designation to navenibart for the treatment of hereditary angioedema (HAE).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Court filing made public
Helene's wake
Walz, Vance VP debate
Teacher wins pronouns case
Strike leads to panic-buying
NASCAR sued by Jordan
Repairman's claims rejected
Doctor pleads guilty
ABC News layoffs
Factory probed after Helene
Historic ship reef plan
Murdaugh's appeal rejected
CO2 found on Pluto's moon
CA food chemicals ban
Bank of America outage
Israel sends more troops
May face additional charges
Man sentenced for cloning
Drop box ban lawsuit
Blasts near Israeli Embassy
Labor board targets Apple
1K troops to aid NC
GA disaster declaration
AG appeals abortion ruling
November trial set
Nintendo opens museum
AR marijuana expansion suit
Port strike hits day 2
AZ voter registration glitch
Feedback